Introduction
Gene expression vectors are useful for monitoring expression in human cells and complementation studies of genetic disorders for gene therapy. Different types of vectors have been utilised for efficient and intact transfer across the cell membrane. Non-viral methods have included transfer of genes in conjunction with liposomes, peptides, polymers, transposases or naked DNA introduced mechanically via electroporation, microinjection, sonoporation, magnetofection and gene gun delivery. Viral vectors include retrovirus, adenovirus adenoassociated virus, lentivirus, alphavirus, baculovirus and herpes virus [1] . Most gene delivery vectors can accommodate several small genes or a single large gene as the cDNA up to 14 kb. However, regulatory sequences surrounding the gene may also be required for full expression. For larger genes, genomic clones as bacterial or yeast artificial chromosomes (BAC, YAC) were constructed to incorporate whole loci up to several hundred kilobases in size, however delivery of these larger vectors into cells was inefficient due to ectopic DNA degradation following transfer [2] .
We developed a successful method to transfer large DNA intact in human artificial chromosome vectors (HAC) modified with Herpes Virus Simplex −1 (HSV-1) sequences as amplicons for delivery [3] . HAC vectors are autonomous, non-integrating vectors that incorporate larger genomic sequences. Once formed as a functional artificial chromosome within the cell, they can be detected and monitored by fluorescent in situ hybridisation (FISH) and immunoFISH. HAC amplicons efficiently form HAC in a variety of cell types including human embryonic stem cells, and genes are effectively expressed from the HAC [3, 4] . The size of the insert DNA in the amplicon is 150 kb, which is the packaging capacity of the virion [5] . The HAC vector requires approximately 40 kb of alpha satellite (alphoid, α) DNA to seed the formation of a new centromere and develop a stable HAC, and the remaining 110 kb is available for incorporating therapeutic genes and their regulatory regions. Previously, we showed that the HSV-1 amplicon HAC system is ideal for single gene delivery. However, genetic disorders resulting from possible defects in large genes, gene locus or multiple genes (polygenic) would require multigenic delivery into cells for complementation of the defect and full gene expression. Developing a single HAC vector containing more than one large gene or an extended gene loci would pose https://doi.org/10.1016/j.yexcr.2020.111840 Received 29 November 2019; Accepted 9 January 2020 major cloning challenges in vector construction. This study investigated whether the simultaneous co-infection of two different HSV-1 amplicon containing HAC vectors, would generate a single HAC with genes appropriately expressed. Previous reports using baculovirus have shown that human cells can be simultaneously infected with multiple viruses and sustain transient multigene expression [6] . However, baculovirus has a capacity of up to 38 kb only [7] .
In the initial experiment, an HSV-1 amplicon containing a HAC vector with chromosome 17α DNA, and a second HSV-1 amplicon containing 21α DNA were introduced into HT1080 cells. A functional HAC containing both 17α and 21α DNA was formed in these cells. In a further experiment, a HSV-1 amplicon containing a HAC vector with 17α DNA and a marker gene, and a second HSV-1 amplicon containing the hypoxanthine guanine phosphoribosyl transferase (HPRT) gene but lacking alphoid DNA, were co-transduced into human cells to determine if a single stable artificial chromosome would be generated containing the HPRT gene. Our results showed that a functional artificial chromosome containing 17α DNA and the HPRT gene was formed, indicating that the presence of alphoid DNA is only required in one HAC vector to seed a functional HAC following co-transduction of two amplicons. The HPRT gene was expressed, and the HPRT defect was complemented in the HT1080 deficient cells.
The major advantage of the co-transduction technique, is that additional HSV-1 amplicons containing gene HAC vectors can exploit the full size carrying capacity (150 kb) of the amplicon without the need to incorporate centromeric alphoid DNA in each HSV-1 amplicon HAC vector that is co-transduced into cells.
Materials and methods

Vectors
The 17 RFP vector is an approximately 140 Kb construct, comprising a BAC backbone carrying 120 kb of human α DNA from chromosome 17, the RFP gene under control of the HSV-1 immediate/early promoter, the blasticidin resistance gene under control of the pUB promoter, and the HSV-1 origin of replication (OriS) and packaging (pac) elements [8] .
The 21 GFP (75 Kb) and HPRT GFP (8 Kb) vectors were described previously [3] . Briefly, both constructs contain the G418 resistance gene under the control of the SV40 promoter, the GFP gene under control of HSV-1 immediate/early promoter, the HPRT minigene, under control of the PGK gene promoter as well as the OriS and pac elements. In addition 21 GFP also contains 60 kb of alphoid DNA, from chromosome 21.
Cell lines
HT1080 cells (wild type WT, and HPRT-, ATCC CCL-121) were grown in Dulbecco's modified Eagle (DMEM) high glucose (Sigma Aldrich) 10% foetal bovine serum (FBS), supplemented with 1x GlutamaxTM-1 (Sigma Aldrich), penicillin 100 U/ml (Sigma Aldrich) and streptomycin 100 μg/ml (Sigma Aldrich). G16-9 [3] cells were grown in the same medium, with the addition of 200 μg/ml hygromycin (InVivoGen). The human induced pluripotent stem cell (hiPS) line DF19-9-11T.H was obtained from WiCell Research Institute (Wisconsin, USA). The human embryonic cells (hESc) HUES-2 cells were obtained from Douglas Melton (Harvard University, USA) under the license from the UK Stem Cell Steering Committee. The hiPS and hESc were grown on inactivated mouse embryo fibroblasts (iMEFs) medium composed of DMEM-F/12(Sigma Aldrich) medium supplemented with 20% (v/v) KnockOut Serum Replacement (ThermoFisher Scientific), 0.1 mM nonessential amino acids (Sigma Aldrich), 1x GlutamaxTM-1 (Sigma Aldrich), 0.1 mM β-mercaptoethanol, 10 ng/ml basic fibroblast growth factor (ThermoFisher Scientific) and 1% (v/v) penicillin and streptomycin.
Amplicon preparation and transduction
Amplicons were prepared and concentrated as described previously [3, 4] . For dual transduction, cells were seeded into 6 well-plates and simultaneously transduced at multiplicity of infection (MOI) 1 and 5 of both amplicons types, in 1 ml of culture medium. The plate was then centrifuged at 750g for 45 min [10] . The HT1080 cells were co-transduced with 17 RFP and 21 GFP or HPRT GFP, selection was applied after 24 h with 5 μg/ml blasticidin and 120 μg/ml G418 and/or HAT 1x (Sigma Aldrich) and monitored until individual clones were observed.
FISH and ImmunoFISH
Metaphase spread preparation and FISH was carried out as described previously [3, 4, 9] . For immunoFISH, metaphase spreads fixed in Carnoy's fixative were stained with anti-Cenp C (Abcam ab50974) and hybridised according to Beh and colleagues [11] .
HPRT analysis
Protein extracts were prepared using the Total Protein Extraction kit (Merck Millipore), according to the manufacturer instructions. Western blots were probed with anti-HRPT (Abcam ab10479) and anti GAPDH (Abcam ab9485) antibodies, detected with HRP conjugated secondary antibodies.
Total RNA was extracted using the RNeasy Mini Kit (Qiagen) following manufacturers' instructions, and reverse transcribed with the Quanta Biosciences qScript cDNA super mix system. Quantitative real time analysis of HPRT expression was conducted using Biorad Sybergreen with the following primers: HPRT F 5′-GCCCCAAAATGGT TAAGGTT-3′ HPRT R 5′-CAAGGGCATATCCAACAACA-3'; GAPDH F 5′-GAGTCAACGGATTTGGTCGT-3′ GAPDH R 5′-GACAAGCTTCCCGTT CTCAG-3. The quantitative RT-PCR data was analysed using the 2 −ΔCt method.
Results
To determine if the two HAC vectors would form a single functional HAC via HSV-1 amplicon delivery, co-transduction experiments were set up using two different HSV-1 amplicons, one containing the HAC vector with 17α DNA and RFP (17 RFP), and the other amplicon containing HAC vector DNA with 21α DNA and GFP (21 GFP) ( Fig. 1 ). Both HSV-1 HAC amplicons were introduced simultaneously into HT1080 cells, and monitored after 24 h by GFP and RFP fluorescence. In a second experiment, co-transductions were set up with HSV-1 amplicons containing HAC vectors with 17 RFP in one amplicon, and a second HSV-1 amplicon carrying the HPRT minigene and GFP as HPRT GFP (Fig. 1A) . Both of the amplicons were co-transduced into HT1080, G16-9, human ES (hES) and induced pluripotent stem (iPS) cells.
Generation of a HAC following co-transduction of two HSV-1 amplicons
Following co-transduction of two HSV-1 HAC amplicons, one with 17 RFP and the other with 21 GFP into HT1080 cells at MOI 1 and 5, the cells expressing GFP + RFP were monitored after 24 h and compared to those expressing either GFP or RFP alone ( Fig. 2A) . The co-transduction efficiencies were determined depending on the MOI titre used. An additional centrifugation step of amplicons at MOI 1 prior to addition to the cells improved the yield (Table 1 ). In total, 13 positive clones were isolated after selection and 6 were expanded for further analysis. Chromosome metaphase spreads prepared from the 6 clones were analysed by FISH with the 17 and 21 alphoid DNA probes, and im-munoFISH with CENP-C. HAC were detected in 2 clones, in up to 40% cells, and integrated DNA was also detected in other cells. Fig. 3A shows the FISH analysis of one clone D3-3, stably carrying the HAC produced from the two inserts, with signal for both the 17α and 21α DNA probes. Positive CENP C staining was also detected on the HAC confirming that a functional centromere had formed [8] . Clone D3.3 was grown in the absence of selection for 30 days to determine the HAC stability. The percentage of HAC containing cells did not change over time, confirming that the HAC possessed and maintained a fully functional centromere.
Gene expressing HAC
Two HSV-1 HAC amplicons, 17 RFP and HPRT GFP were co-transduced into human HT1080 (HPRT-), G16-9, hES (HUES 2) and iPS (DF19.9) cells at MO1 2 and appropriate selection applied. The transduced HT1080 (HPRT-) cells were also selected with HAT to detect functional HPRT containing cells. Table 2 , indicates the co-transduction efficiency in different cell lines 24 h after transduction, where cells were monitored for expression of GFP + RFP (Fig. 2B) . The results showed a high frequency of colocalised RFP + GFP cells in all cell lines transduced, which gave rise to clonal populations showing the expression of both markers (Fig. 3B ).
Further analysis was performed in HT1080 HPRT-cells. Seventeen positive clones were isolated and expanded, and chromosome metaphase spreads prepared from 10 clones. Metaphase spreads were analysed by FISH with the 17α and HPRT DNA probes. Positive HACs with both signals were detected in all cell lines from 20 to 70% of cells, and some cells also contained integrated DNA (Fig. 3A) . One clone, LWB5 was analysed by immunoFISH and CENP-C was detected on the HAC (unpublished results). HPRT expression from the LWB5 HAC was analysed by Western blot with an anti-HPRT antibody, which detected the presence of HPRT protein in HT1080 HPRT-cells (Fig. 3C) . The intensity of the HPRT band in the LWB5 sample indicates that this protein is present in a higher amount compared to the WT HT1080 cells. This was expected since the HPRT gene expression was driven by a strong constitutive promoter. Quantitative RT-PCR data of LWB5 showed expression of the HPRT gene and confirmed that the defect in HT1080 HPRT-cells was complemented.
Discussion
In this study, we built on previous work where we showed that HSV-1 amplicons containing the vector DNA with sequences for an artificial chromosome including 40 kb of 17 alphoid DNA could generate a functional HAC in human cells including human embryonic stem and neural cells [4] . The results from the present study showed that when two HSV-1 amplicons containing different HAC constructs were introduced into human cells with the aim of generating an artificial chromosome, the exogenous DNAs recombined to generate a single HAC. In initial experiments, two HSV-1 amplicons containing either chromosome 17α or 21α HAC vector DNA were co-transduced into HT1080 cells. Positive clones were identified following selection. One clone D3-3 was analysed in detail by FISH and immunoFISH, and contained a single functional HAC with both 17α and 21α DNA present. The efficiency of co-transduction of the two amplicons relative to the transduction of a single amplicon was comparable in HT1080 cells. In this experiment, MOI 1 following centrifugation of amplicons was found to be more efficient than MOI 5 without centrifugation prior to transduction. In general, the centrifugation of amplicons gives better transduction efficiencies at the MOI used, and we routinely utilise the process prior to transduction.
In a further experiment, we showed that two HSV-1 amplicons, one containing a vector with 40 kb of 17 alphoid DNA and the other with the HPRT gene but lacking alphoid DNA, could form a single HPRT HAC in human HT1080 HPRT-, G16-9, hES and iPS cells. Following selection, we observed co-localisation of both vectors by RFP + GFP fluorescence in all cell lines transduced at a reasonable frequency. At MOI 2 the frequency of co-transduction, in the hES and iPS cells was comparable to that observed in the HT1080 and G16-9 cultured cells although lower than each amplicon transduced singly. In HT1080 HPRTcells, the FISH and immunoFISH analysis on one of the positive clones identified LWB5, confirmed that a functional HPRT HAC was generated. Analysis of RNA and protein levels in LWB5 indicated that the HPRT gene was expressed and complemented the HPRT deficiency.
Conclusion
The work presented successfully showed that simultaneous co-infection of two separate HSV-1 amplicons containing different input DNA is an efficient delivery method for studying multigene expression from a HAC generated following co-transduction. The results further show that only one of the HSV-1 amplicons is required to contain 40 kb of alphoid DNA to generate a functional HAC containing the input DNA sequences from both amplicons. The strategy doubles the capacity of the artificial chromosome vectors to accommodate larger stretches of DNA, genes or gene loci within each HSV-1 amplicon, compared to the transfer of a single HSV-1 HAC vector containing amplicon. The results indicate that DNA size will not be a limitation to the HSV-1 amplicon system. Several amplicons containing different genes could be cotransferred simultaneously, and gene expression monitored from the HAC generated within the cells. This study offers a promising approach for studying large genes or multigene expression in a variety of different biochemical systems or complex diseases in human cells, including human embryonic and induced pluripotent cells, and ultimately for gene therapy.
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